Canton Strategic Holdings (CNTN) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Canton Strategic Holdings

NasdaqCM•Healthcare•Biotechnology

$2.21-0.02(-0.01%)Pre-market

Market Cap

$455.42M

P/S

304.5x

P/B

1.0x

Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology. The company is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasury expansion; token management - locking, lending, and options; Canton Foundation; and governance and risk management. It also researches and develops GV104, a buccal film formulation of nalmefene for the treatment of respiratory depression and prophylactic protection against synthetic opioid exposure in military and first responders; and GV023, an oral anti-tumor necrosis factor-alpha monoclonal antibody that addresses critical limitation of IV gold standard for the treatment of repeated intravenous infusions. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is headquartered in Red Bank, New Jersey.

How this company scores

WeakMetricSide Score: 38/100

Strongest: Balance Sheet & Red Flags (15/25); weakest: Cash & Earnings Quality (5/25).

Profitability11/25

Growth7/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality5/25

Strengths

Long cash runwayInterest easily coveredNet cash positionImproving margins

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/S · 304.5x5y range 304.5x – 304.5x

P/B · 1.0x5y range 0.2x – 477.8x

Currently below its 17-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

Free cash flow has been negative in 7 of the last 8 quarters — earnings are not translating to cash.

Price & Volume

Market Cap $455.42M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $1.50M
Q. Revenue: $1.50M
TTM EBITDA: $-53.78M
TTM Op. Income: $-53.78M
Q. Op. Income: $-1.20M
TTM Net Income: $-98.12M
Q. Net Income: $-19.25M
EPS: N/A
Shares Out.: $216.86M

$1.50M in TTM revenue grew from zero YoY, reaching $1.50M last quarter. TTM EBITDA of $-53.78M and TTM operating income of $-53.78M show growth is flowing through to the bottom line. However, net income is negative at $98.12M — growth is not yet reaching the bottom line. Over the past year, TTM revenue is up 0% — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: -80.4%
Op. Margin: -80.4%
Net Margin: -1287.2%

Op. margin of -80.4% is up 185115919.6% YoY — cost efficiency is improving. Net margin at -1287.2% Over the past year, operating margin is up 100% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 304.5x
P/B Ratio: 1.0x

P/S of 304.5x and P/B of 1.0x. P/S is high, meaning growth expectations are priced in.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $564.57M
Cash: $37.24M
Long-Term Debt: N/A
Book Value: $454.90M
D/E Ratio: N/A
Debt/EBITDA: N/A

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $2.21M
TTM Free Cash Flow: $-17.72M
FCF Margin: -1184.7%
FCF / Net Income: 0.2

TTM FCF of $-17.72M on $2.21M in operating cash flow. The FCF / Net Income ratio of 0.2x means cash covers only part of net income — earnings quality needs attention. Over the past year, free cash flow is down 82% — an improving trend.